EXOASO-STAT6 Trademark

Trademark Overview

On Wednesday, September 21, 2022, a trademark application was filed for EXOASO-STAT6 with the United States Patent and Trademark Office. The USPTO has given the EXOASO-STAT6 trademark a serial number of 97601016. The federal status of this trademark filing is REGISTERED as of Tuesday, December 26, 2023. This trademark is owned by Codiak Biosciences, Inc.. The EXOASO-STAT6 trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biologic preparations for use in oncology and immuno-oncology; biological components being a component in therapeutic preparations, namely, engineered exosomes delivering antisense oligonucleotides to inhibit tumor growth and induce anti-tumor immune response; therapeutic agents for the treatment of cancer and immuno-oncological diseases; therapeutic agents for inducing anti-tumor immune response
exoaso-stat6

General Information

Serial Number97601016
Word MarkEXOASO-STAT6
Filing DateWednesday, September 21, 2022
Status700 - REGISTERED
Status DateTuesday, December 26, 2023
Registration Number7256367
Registration DateTuesday, December 26, 2023
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 4, 2023

Trademark Statements

Goods and ServicesPharmaceutical and biologic preparations for use in oncology and immuno-oncology; biological components being a component in therapeutic preparations, namely, engineered exosomes delivering antisense oligonucleotides to inhibit tumor growth and induce anti-tumor immune response; therapeutic agents for the treatment of cancer and immuno-oncological diseases; therapeutic agents for inducing anti-tumor immune response
Pseudo MarkEXOASO STAT SIX

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 6, 2022
Primary Code005
First Use Anywhere DateMonday, February 20, 2023
First Use In Commerce DateMonday, February 20, 2023

Trademark Owner History

Party NameLONZA SALES AG
Party Type30 - Original Registrant
Legal Entity Type11 - Company
AddressBASEL CH-4052
CH
Party NameLONZA SALES AG
Party Type21 - New Owner After Publication
Legal Entity Type11 - Company
AddressBASEL CH-4052
CH
Party NameCodiak Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140
Party NameCodiak Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140

Trademark Events

Event DateEvent Description
Saturday, September 24, 2022NEW APPLICATION ENTERED
Thursday, October 6, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 21, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 24, 2023ASSIGNED TO EXAMINER
Friday, January 27, 2023NON-FINAL ACTION WRITTEN
Friday, January 27, 2023NON-FINAL ACTION E-MAILED
Friday, January 27, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 21, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 22, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 27, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 4, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 4, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 30, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, July 12, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, July 14, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, July 14, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, July 14, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 14, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 14, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 30, 2023USE AMENDMENT FILED
Monday, October 30, 2023TEAS STATEMENT OF USE RECEIVED
Thursday, November 9, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, November 16, 2023STATEMENT OF USE PROCESSING COMPLETE
Friday, November 17, 2023SU - NON-FINAL ACTION - WRITTEN
Friday, November 17, 2023NON-FINAL ACTION E-MAILED
Friday, November 17, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 20, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, November 21, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 26, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 26, 2023REGISTERED-PRINCIPAL REGISTER
Monday, September 30, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 30, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 30, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Related Keywords

stat exoaso therapeutic tumor immune anti response immuno agents preparations oncology induce